Troy Wichterman - 20 Mar 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Financial Officer
Signature
/s/ Troy Wichterman
Issuer symbol
BLFS
Transactions as of
20 Mar 2023
Net transactions value
-$211,238
Form type
4
Filing time
22 Mar 2023, 19:59:01 UTC
Previous filing
09 Mar 2023
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Options Exercise $1,932 +938 +1.2% $2.06* 78,160 20 Mar 2023 Direct
transaction BLFS Common Stock Sale $206,400 -10,000 -13% $20.64 68,160 20 Mar 2023 Direct F1, F2
transaction BLFS Common Stock Sale $6,770 -310 -0.45% $21.84 67,850 22 Mar 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLFS Stock Option Options Exercise $0 -938 -100% $0.000000* 0 20 Mar 2023 Common Stock 938 $2.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 15, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $20.76, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.